Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 2/20 | 0.40 |
| ▸ | ACACB | O00763 | 10/20 | 0.37 |
| ▸ | ESR1 | P03372 | 1/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | APEX1 | P27695 | 1/20 | 0.32 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | RAD51 | Q06609 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6805279 | 0.92 | CNR1 (0.42) | CNR1ACACBESR1KCNH2GAA | |
| SCHEMBL6681192 | 0.85 | CNR1 (0.40) | CNR1ACACBESR1KCNH2GAA | |
| SCHEMBL6804246 | 0.84 | CNR1 (0.43) | CNR1ACACBESR1KCNH2GAA | |
| SCHEMBL6681129 | 0.83 | CNR1 (0.42) | CNR1ACACBESR1KCNH2GAA | |
| SCHEMBL6678499 | 0.81 | ACACB (0.41) | CNR1ACACBESR1KCNH2GAA | |
| SCHEMBL6805179 | 0.80 | CNR1 (0.56) | CNR1ACACB | |
| SCHEMBL6809464 | 0.80 | ESR1 (0.42) | CNR1ACACBESR1KCNH2GAA | |
| SCHEMBL6676664 | 0.79 | CNR1 (0.41) | CNR1ACACBESR1KCNH2GAA | |
| SCHEMBL6809647 | 0.79 | ESR1 (0.36) | ACACBESR1KCNH2TAAR1CYP1A2 | |
| SCHEMBL6677150 | 0.78 | CYP1A2 (0.51) | ACACBESR1KCNH2CYP1A2CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040106653-A1 | Aminoalcohol derivatives | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2004-06-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040106653-A1 | Aminoalcohol derivatives | FANCD2, FANCI, HRH2 | CNR1 112/4885ACACB 1800/4885ESR1 3850/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.